article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. One of its most useful aspects is that answers to many questions come readily from data analysis.

article thumbnail

European PFAS restriction could jeopardise pharmaceutical manufacturing

European Pharmaceutical Review

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sustainable energy strategies for pharmaceutical manufacturers

European Pharmaceutical Review

The pharmaceutical sector is not typically seen as a highly polluting, ‘heavy industry’ but it is far from green. In its 2021 report Delivering a ‘Net Zero’ National Health Service , the UK’s NHS attributes as much as a quarter of its carbon footprint to medicines. About the author.

article thumbnail

New medicines manufacturing centre to enhance UK talent

European Pharmaceutical Review

million to establish a Medicines Manufacturing Skills Centre of Excellence. Enhancing talent in pharmaceutical manufacturing “Talent and skills are fundamental to successful innovation and industry growth. The UK government is investing £5.5

article thumbnail

Sustainable pharmaceutical manufacturing: buzzword bingo or forthcoming reality?

PharmaTech

What actions can we as manufacturers take to make a difference to sustainability without disrupting the supply of our life-saving medicines?

article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control.

Pharma 127
article thumbnail

Big Pharma inventory management trends revealed

European Pharmaceutical Review

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. While the COVID-19 pandemic depleted demand for some medicines, the year-end saw widely-reported shortages of many medicines. billion, representing a significant waste of capacity and resources.